| __timestamp | Evotec SE | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 22223073 |
| Thursday, January 1, 2015 | 18343000 | 6966842 |
| Friday, January 1, 2016 | 18108000 | 9000499 |
| Sunday, January 1, 2017 | 17614000 | 13741186 |
| Monday, January 1, 2018 | 35619000 | 19040000 |
| Tuesday, January 1, 2019 | 58432000 | 23559000 |
| Wednesday, January 1, 2020 | 63945000 | 31931000 |
| Friday, January 1, 2021 | 72200000 | 44981000 |
| Saturday, January 1, 2022 | 76642000 | 54234000 |
| Sunday, January 1, 2023 | 57519000 | 63806000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, innovation is the key to success. Over the past decade, Viking Therapeutics, Inc. and Evotec SE have been at the forefront of this innovation race. From 2014 to 2023, both companies have significantly increased their investment in research and development (R&D), a crucial indicator of their commitment to innovation.
Evotec SE, a German-based company, has consistently increased its R&D spending, peaking in 2022 with a 520% increase from 2014. Meanwhile, Viking Therapeutics, a U.S.-based firm, has shown an even more dramatic rise, with a 187% increase in R&D expenses over the same period, surpassing Evotec SE in 2023.
This trend highlights the fierce competition and dedication to innovation in the biotech industry, as both companies strive to lead in groundbreaking research and development.
Johnson & Johnson or Evotec SE: Who Invests More in Innovation?
R&D Insights: How Pfizer Inc. and Evotec SE Allocate Funds
R&D Spending Showdown: Bristol-Myers Squibb Company vs Evotec SE
Comparing Innovation Spending: United Therapeutics Corporation and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Neurocrine Biosciences, Inc. vs Viking Therapeutics, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Evotec SE
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Evotec SE
Halozyme Therapeutics, Inc. vs Evotec SE: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Protagonist Therapeutics, Inc.
Viking Therapeutics, Inc. and Evotec SE: SG&A Spending Patterns Compared
Who Prioritizes Innovation? R&D Spending Compared for Evotec SE and Novavax, Inc.